抗前蛋白轉化酶枯草溶菌素9(PCSK9)單克隆抗體
Anti-Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Monoclonal Antibody
FH3; HCHOLA3; NARC1; Hypercholesterolemia,Autosomal Dominant 3; Neural apoptosis-regulated convertase 1; Proprotein convertase 9; Subtilisin/kexin-like protease PC9
- 編號FAE189Ra02
- 物種Rattus norvegicus (Rat，大鼠)相同的名稱，不同的物種。
- 效價-
- Ig亞型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 激發(fā)波長
- 單次使用量
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 且適物種Mus musculus (Mouse，小鼠)
- 應用FCM
- 下載英文說明書 中文說明書
- 規(guī)格25test50test100test200test500test
- 價格¥ 792¥ 1320¥ 2112¥ 2640¥ 4620
- 欲了解實際交易價格和更多情況，請與當地經銷商聯(lián)系!
產品包裝(模擬)
產品包裝(模擬)
Mouse Hepa1-6 cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 10μg/ml mouse Anti-rat PCSK9 Monoclonal Antibody (Catalog FAE189Ra02, red histogram) or Isotype control antibody (Catalog IS067-Mu03, green histogram), followed by 1μg/ml FITC-conjugated Anti-mouse IgG Secondary Antibody (Catalog SAA544Mu18).
通過ISO 9001、ISO 13485質量體系認證
用法
Flow cytometry: 10μg/ml;
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過一年。避免反復凍融。
贈品
增值服務
相關產品
| 編號 | 適用物種：Rattus norvegicus (Rat，大鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPE189Ra01 | 前蛋白轉化酶枯草溶菌素9(PCSK9)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAE189Ra01 | 前蛋白轉化酶枯草溶菌素9(PCSK9)多克隆抗體 | WB; IHC; ICC; IP. |
| MAE189Ra23 | 前蛋白轉化酶枯草溶菌素9(PCSK9)單克隆抗體 | IHC |
| MAE189Ra22 | 前蛋白轉化酶枯草溶菌素9(PCSK9)單克隆抗體 | WB |
| MAE189Ra21 | 前蛋白轉化酶枯草溶菌素9(PCSK9)單克隆抗體 | WB; IHC |
| FAE189Ra02 | 抗前蛋白轉化酶枯草溶菌素9(PCSK9)單克隆抗體 | FCM |
| SEE189Ra | 前蛋白轉化酶枯草溶菌素9(PCSK9)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LME189Ra | 前蛋白轉化酶枯草溶菌素9(PCSK9)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Biological Trace Element Research | Synergistic Cardioprotective Effects of Combined Chromium Picolinate and Atorvastatin Treatment in Triton X-100-Induced Hyperlipidemia in Rats: Impact on Some Biochemical Markers[pubmed:28409410] |
| BASIC RESEARCH IN CARDIOLOGY | Autocrine effects of PCSK9 on cardiomyocytes[Pubmed: 33169229] |
| J Transl Med | Multi-omic signatures of atherogenic dyslipidaemia: pre-clinical target identification and validation in humans[33407555] |
| Metabolism | MiR-337-3p lowers serum LDL-C level through targeting PCSK9 in hyperlipidemic mice[33775647] |
| Eur Rev Med Pharmacol Sci | Association of serum proprotein convertase Subtilisin/Kexin Type 9 (PCSK9) level with thyroid function disorders[34533801] |
| Clin Exp Hypertens | Proprotein convertase subtilisin/kexin type 9 is associated with atherosclerosis in patients with Behcet's disease[Pubmed:35502687] |